- Filed
- Aug 6, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 5, 2024 | 41.44M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2024 | 41.19M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2024 | 41.2M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 41.28M sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 41.14M sh |
| Stock Repurchased | Q2 2024 · Jun 30, 2024 | $1.15M |
| Stock Repurchased | Q2 2024 · Jun 30, 2023 | $1.64M |
| Capex | Q2 2024 · Jun 30, 2024 | $5.68M |
| Capex | Q2 2024 · Jun 30, 2023 | $10.43M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2024 | −$33.24M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $97.25M |
| Stockholders Equity | Q2 2024 · Jun 30, 2024 | $1.9B |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | $2.4B |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $2.4B |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $2.35B |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $2.35B |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $2.39B |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $16.46B |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $16.63B |
| Total Assets | Q2 2024 · Jun 30, 2024 | $18.36B |
| Total Assets | Q2 2024 · Dec 31, 2023 | $19.04B |
| Eps Diluted | Q2 2024 · Jun 30, 2024 | −$11.93 |
| Eps Diluted | Q2 2024 · Jun 30, 2024 | −$11.35 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.80 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.11 |
| Eps Basic | Q2 2024 · Jun 30, 2024 | −$11.93 |
| Eps Basic | Q2 2024 · Jun 30, 2024 | −$11.35 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.80 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.11 |
| Net Income | Q2 2024 · Jun 30, 2024 | −$493.46M |
| Net Income | Q2 2024 · Jun 30, 2024 | −$469.31M |
| Net Income | Q2 2024 · Jun 30, 2023 | $33.08M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$4.43M |